PRKCB and sarcoma: However, the high expressions of ARF3 and PRKCB were significantly associated with longer overall survival (P = 0.0018 and P = 0.0162), indicating that ARF3 and PRKCB overexpression could be positive prognostic factors in sarcoma patients.